Wang Yuanliang, Liang Guobiao, Tian Jing, Wang Xin, Chen Anjian, Liang Tiancai, Du Yang, Li Hao, Du Jiang, Yu Lang, Chen Zongping
Department of Urology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China.
Department of Anesthesiology, Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563000, P.R. China.
Oncol Lett. 2018 Apr;15(4):4882-4890. doi: 10.3892/ol.2018.7957. Epub 2018 Feb 5.
The objective of the present study was to systematically investigate the clinical features, diagnosis and therapeutic treatment of Von Hippel-Lindau (VHL) syndrome in order to improve understanding of this disease. A total of 3 cases of VHL syndrome treated at the Affiliated Hospital of Zunyi Medical College (Zunyi, China) between September 2014 and October 2015 were retrospectively analyzed. The associated literature was reviewed, and the diagnostic and therapeutic features were discussed. Case 1 was diagnosed as VHL syndrome accompanied by a renal tumor on the right side, and radical tumor resection in the right kidney was performed. Postoperative pathological examination indicated clear cell carcinoma. Case 2 was diagnosed as VHL syndrome accompanied by bilateral adrenal pheochromocytoma. The left-side adrenal tumor was removed, and postoperative pathological analysis was suggestive of adrenal pheochromocytoma. Case 3 visited the hospital due to the presence of masses on the left and right sides of the kidney, but did not undergo surgery for personal reasons. Follow-ups were scheduled subsequent to surgery at another hospital. The diagnosis in all 3 cases was confirmed by genetic testing, where VHL mutations were detected in all patients. Following surgery, pedigree and genetic analysis was performed in all 3 pedigrees and VHL mutations were identified in 7 family members. The diagnosis of VHL syndrome should be based on the clinical manifestation of the patients and the results of genetic tests. DNA analysis of mutations is the main method for diagnosis. An appropriate surgical plan should be formulated based on the site, size and number of tumors, and the condition of the patient. Since VHL syndrome is an inheritable genetic disorder and relapse following surgery is common, pedigree analysis of the patient and lifelong follow-ups are essential. Additionally, physicians should pay attention to VHL syndrome in order to avoid missing diagnosis or misdiagnosis.
本研究的目的是系统地调查冯·希佩尔-林道(VHL)综合征的临床特征、诊断和治疗方法,以增进对该疾病的了解。对2014年9月至2015年10月期间在遵义医学院附属医院(中国遵义)接受治疗的3例VHL综合征患者进行了回顾性分析。查阅了相关文献,并对诊断和治疗特征进行了讨论。病例1被诊断为VHL综合征伴右侧肾肿瘤,行右肾肿瘤根治性切除术。术后病理检查显示为透明细胞癌。病例2被诊断为VHL综合征伴双侧肾上腺嗜铬细胞瘤。切除左侧肾上腺肿瘤,术后病理分析提示为肾上腺嗜铬细胞瘤。病例3因双侧肾肿块前来就诊,但因个人原因未接受手术。在另一家医院手术后安排了随访。所有3例患者均通过基因检测确诊,所有患者均检测到VHL突变。手术后,对所有3个家系进行了家系和基因分析,在7名家庭成员中鉴定出VHL突变。VHL综合征的诊断应基于患者的临床表现和基因检测结果。突变的DNA分析是主要的诊断方法。应根据肿瘤的部位、大小和数量以及患者的情况制定合适的手术方案。由于VHL综合征是一种遗传性疾病,术后复发很常见,因此对患者进行家系分析和终身随访至关重要。此外,医生应关注VHL综合征,以避免漏诊或误诊。